Shenzhen
Meridan ReportShenzhen: Hardware capital of the world

Advertisement · Why this ad?

Business

Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge

Katherine Langford
Editor-in-Chief · Monday, October 26, 2026 at 1:04 PM · 1 min read
Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge — South China Morning Post, Shenzhen Business news
Image: South China Morning Post

WuXi AppTec raised its full-year revenue guidance after its net profit surged 62.4 per cent in the first nine months of 2026, while revenue rose 38.6 per cent on strong demand for its drug development and manufacturing services. The Chinese pharmaceutical research services provider’s net profit reached 19.16 billion yuan (US$2.87 billion) for the nine months ended September 30, compared with 11.80 billion yuan a year earlier, a filing to the Hong Kong stock exchange showed. Its revenue rose to...

Up nextHong Kong proposes more homes, less office space at Hung Hom harbourfrontBusiness · 1 min read
#development
You're offline — showing the last loaded page